Advertisement Bioniche to introduce new products in Australia, North America - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Bioniche to introduce new products in Australia, North America

Bioniche Life Sciences, a Canada-based developer of products for human and animal health markets , is set to introduce Cue-Mare and Tri-Otic Ointment in Australia, and Peridan Concentrate in North America.

Cue-Mare is used for the induction of estrous in spring transitional mares, which is particularly important to enable early breeding.

Tri-Otic Ointment is a canine treatment for acute and chronic Otitis externa (inflammation of the outer ear and ear canal) that is associated with yeast and/or bacteria susceptible to gentamicin.

Peridan Concentrate is instilled into the abdominal cavity during surgical procedures, creating a physical barrier between damaged tissues that helps reduce the formation of potentially dangerous post-surgical adhesions.